Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Grant Julie Papanek. Insider active across 1 company, notably Day One Biopharmaceuticals, Inc.. In total, 10 reports have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €17.6m. Activity tracked since 13 September 2022. The latest transaction was disclosed on 1 March 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations10 total
25,000 shares@ US$18.61212.5% of flowCommon StockSEC:0001209191-23-015850:0
23,894 shares@ US$21.21062.6% of flowCommon StockSEC:0001209191-23-006945:0
17,390 shares@ US$20.3551.9% of flowCommon StockSEC:0001209191-23-001275:0
4,358 shares@ US$22.07670.5% of flowCommon StockSEC:0001209191-22-060728:0
4,760 shares@ US$21.72130.6% of flowCommon StockSEC:0001209191-22-059727:0
5,000 shares@ US$20.04170.6% of flowCommon StockSEC:0001209191-22-055596:0
5,000 shares@ US$20.0630.6% of flowCommon StockSEC:0001209191-22-052756:0
607,497 shares@ US$18.5465.1% of flowCommon StockSEC:0000899243-22-031691:0
111,585 shares@ US$21.5313.7% of flowCommon StockSEC:0000899243-22-031605:0
86,644 shares@ US$24.3912.0% of flowCommon StockSEC:0000899243-22-031193:0